Skip to search formSkip to main contentSkip to account menu

Forced Expiratory Volume in 1 Second Reversibility

Known as: FEV1 Reversibility, FEV1REV 
The change in FEV1 following administration of a bronchodilator relative to the pre-treatment FEV1 value. (CDISC)
National Institutes of Health

Related topics

Related topics

2 relations
CDISC SDTM Respiratory Test Name TerminologyClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
In patients with severe asthma with eosinophilia in reslizumab clinical trials, high peripheral blood eosinophil levels are associated with low FEV1 reversibility
A post hoc analysis of two randomized, placebo–controlled, Phase 3 trials of intravenous reslizumab, an anti-interleukin-5 (IL-5… 
2019
2019
Blood Eosinophil Counts in Patients with Marked FEV1 Reversibility and Fixed Airflow Obstruction
2019
2019
Post-bronchodilator changes in volumes and airway caliber according to Peak flow and FEV1 reversibility
Background: The possible negative effect of Peak Expiratory Flow (PEF) increase on Forced Expiratory Volume in 1s (FEV1) has been… 
2018
2018
A comprehensive approach to lung function in bronchiectasis.
2017
2017
Post-bronchodilator Reversibility of FEV1 and Eosinophilic Airway Inflammation in COPD.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)